about
Varicella-zoster virusMode of antiviral action of penciclovir in MRC-5 cells infected with herpes simplex virus type 1 (HSV-1), HSV-2, and varicella-zoster virusVaricella zoster virus. Recent advances in managementFamciclovir for ophthalmic zoster: a randomised aciclovir controlled studyEpstein-Barr virus lytic infection contributes to lymphoproliferative disease in a SCID mouse model.Pharmacologic management of herpes zoster and postherpetic neuralgia.The bioavailability and disposition of 1-(beta-D-arabinofuranosyl)-5-(1-propynyl)uracil (882C87), a potent, new anti-varicella zoster virus agentClinical practice: Herpes zosterNew antiviral and antifungal drugs.Antiviral therapy: current concepts and practicesThe prophylactic role of intravenous and long-term oral acyclovir after allogeneic bone marrow transplantationEpidemiology in general practiceEpidemiology of Herpes Zoster Ophthalmicus: Recurrence and ChronicityTreatment of shingles and post-herpetic neuralgia.Herpes zoster management.Prophylaxis against B virus infection.Approches actuelles au traitement du zona: Aspects controversés du traitement du zona.Acyclovir and post-herpetic neuralgia and ocular involvement.Acyclovir and post-herpetic neuralgia. Two other participating study centres report different resultsAcyclovir and post-herpetic neuralgia. The balance of available evidence supports its use.Lack of effect of acyclovir on postherpetic neuralgia.
P2860
Q24683811-B79339CB-0073-4AA4-A263-6ECC2F6B58ACQ28327167-8CA8CBBD-7695-4389-962D-DBCDDE380C90Q28344239-653B7509-C71B-4CA7-8F4C-3D9125F4C54EQ28363444-EF80CCEA-28D9-4260-92CD-DD2F5693D226Q34123985-A29C7786-A66F-48AA-B467-F9C1964302A3Q34322115-979E591B-508C-4165-A7DC-D9E483F888E0Q34346820-080D3A3E-6523-4CE0-BDE4-5ED9FDA8E354Q34358014-077DB739-25F7-44C9-B981-E3561FCBE276Q35168469-175C36E5-8932-4DE7-AA66-A3CBC1041640Q36070394-8AC3A875-5E2F-445C-8993-58A346721F4AQ36467322-06C5A53B-FCE4-4C5A-9CD2-EAD231FE9E70Q36473153-0CD8C006-750A-49A3-83CD-70661469E919Q37038580-16CF0B3E-BD26-4447-A052-5EAEB75DCA88Q38230330-782D59F6-2FA6-409A-8932-3A986D819A56Q38746961-C95B9F59-CDE7-49E8-A6F4-C281BB7CFA86Q42011993-7DBE214E-0D18-4396-B442-49CD028F4372Q42079336-4253E370-C98A-45BD-AEDB-9B6ABDD2660FQ42186113-777AEDF9-D93D-4E62-A297-FE8DACB72E03Q42848243-8DE68C6E-B48A-422F-8421-B1BD9F4511DCQ42848265-AADF68C8-AA29-4AC4-B89C-BC23D120246AQ42883647-544313ED-3112-4D54-AFAE-5E24D8C53933
P2860
description
1986 nî lūn-bûn
@nan
1986 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1986 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
1986年の論文
@ja
1986年学术文章
@wuu
1986年学术文章
@zh-cn
1986年学术文章
@zh-hans
1986年学术文章
@zh-my
1986年学术文章
@zh-sg
1986年學術文章
@yue
name
Oral acyclovir in acute herpes zoster.
@ast
Oral acyclovir in acute herpes zoster.
@en
Oral acyclovir in acute herpes zoster.
@nl
type
label
Oral acyclovir in acute herpes zoster.
@ast
Oral acyclovir in acute herpes zoster.
@en
Oral acyclovir in acute herpes zoster.
@nl
prefLabel
Oral acyclovir in acute herpes zoster.
@ast
Oral acyclovir in acute herpes zoster.
@en
Oral acyclovir in acute herpes zoster.
@nl
P2093
P1433
P1476
Oral acyclovir in acute herpes zoster.
@en
P2093
P304
P407
P577
1986-12-01T00:00:00Z